GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daiichi Sankyo Co Ltd (OTCPK:DSNKY) » Definitions » EBIT per Share

Daiichinkyo Co (Daiichinkyo Co) EBIT per Share : $0.88 (TTM As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Daiichinkyo Co EBIT per Share?

Daiichinkyo Co's EBIT per Share for the three months ended in Mar. 2024 was $0.09. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.88.

During the past 12 months, the average EBIT per Share Growth Rate of Daiichinkyo Co was 75.50% per year. During the past 3 years, the average EBIT per Share Growth Rate was 49.70% per year. During the past 5 years, the average EBIT per Share Growth Rate was 13.70% per year. During the past 10 years, the average EBIT per Share Growth Rate was 4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Daiichinkyo Co's EBIT per Share or its related term are showing as below:

DSNKY' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -36.2   Med: 1.25   Max: 49.7
Current: 49.7

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Daiichinkyo Co was 49.70% per year. The lowest was -36.20% per year. And the median was 1.25% per year.

DSNKY's 3-Year EBIT Growth Rate is ranked better than
88.5% of 852 companies
in the Drug Manufacturers industry
Industry Median: 7.95 vs DSNKY: 49.70

Daiichinkyo Co's EBIT for the three months ended in Mar. 2024 was $181 Mil.

Daiichinkyo Co EBIT per Share Historical Data

The historical data trend for Daiichinkyo Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daiichinkyo Co EBIT per Share Chart

Daiichinkyo Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.71 0.36 0.35 0.53 0.85

Daiichinkyo Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.20 0.20 0.40 0.09

Daiichinkyo Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Daiichinkyo Co's EBIT per Share for the fiscal year that ended in Mar. 2024 is calculated as

EBIT per Share(A: Mar. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=1623.697/1918.668
=0.85

Daiichinkyo Co's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

EBIT per Share(Q: Mar. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=180.725/1918.720
=0.09

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daiichinkyo Co  (OTCPK:DSNKY) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Daiichinkyo Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Daiichinkyo Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Daiichinkyo Co (Daiichinkyo Co) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daiichi Sankyo Co Ltd (OTCPK:DSNKY) » Definitions » EBIT per Share
Comparable Companies
TSE:4519 TSE:4503 TSE:4578 TSE:4151 TSE:4528 TSE:4536 TSE:4552 TSE:4882 LLY JNJ MRK ABBV XSWX:ROG LSE:AZN XSWX:NOVN PFE AMGN XPAR:SAN BMY GILD
Traded in Other Exchanges
DSKYF:USA 4568:Japan D4S:Germany
Address
3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, JPN, 103-8426
Website
https://www.daiichisankyo.com
Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2021, approximately half of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first U.S approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.